TETRAPHASE PHARMACEUTICALS INC
Profile
Company Names
TETRAPHASE PHARMACEUTICALS INC
Addresses
480 ARSENAL WAY, WATERTOWN, MA 02472
480 ARSENAL STREET, SUITE 110, WATERTOWN, MA 02472
Phone Numbers
617-715-3600
617.715.3600
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2006
State Incorporated:
DELAWARE
Total Amount Raised:
$64,747,939.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-01-24
$9,997,939.00
$9,997,939.00
$0.00
Equity
2
2010-05-14
$44,750,000.00
$45,000,000.00
$250,000.00
Equity
1
2009-09-11
$10,000,000.00
$29,627,203.00
$19,627,203.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
GAREN
BOHLIN
DIRECTOR
STEVEN
BOYD
DIRECTOR
TIGER GLOBAL FB PARTNERS, LLC
| ARMISTICE CAPITAL FUND LP
| ARMISTICE CAPITAL FUND OFFSHORE LTD.
| REVERSE MORTGAGE INVESTMENT TRUST INC.
| ARMISTICE CAPITAL OFFSHORE FUND LTD.
| EYEGATE PHARMACEUTICALS INC
| AYTU BIOSCIENCE, INC
| TETRAPHASE PHARMACEUTICALS INC
| TREBUCHET GRANITE ONSHORE FUND, LP
| TENAX THERAPEUTICS, INC.
| VARSITY EMERGENCY CARE HOLDINGS, LLC
DOUGLAS
COLE
DIRECTOR
LARRY
EDWARDS
EXECUTIVE OFFICER, DIRECTOR
JOHN
G.
FREUND
DIRECTOR
L.
PATRICK
GAGE
DIRECTOR
STEVE
GULLANS
DIRECTOR
DAVID
LUBNER
EXECUTIVE OFFICER
GUY
MACDONALD
DIRECTOR, EXECUTIVE OFFICER
KEITH
MAHER
DIRECTOR
LAWRENCE
MILLER
DIRECTOR
ROBERT
WEISSKOFF
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC
| ACCURI CYTOMETERS INC
| TRANSAVE INC
| IKANO THERAPEUTICS INC.
| ACORN CARDIOVASCULAR INC
| VIEWRAY INC
| BIOCONNECT SYSTEMS INC
| AMPHORA MEDICAL, INC.
| CARIBOU BIOSCIENCES, INC.
| IOWA APPROACH, INC.
| ZENFLOW, INC.
| TEMPEST THERAPEUTICS, INC.
| FARAPULSE, INC.
| CHECKMATE PHARMACEUTICALS, INC.
| AFFINIA THERAPEUTICS INC.
| XILIO THERAPEUTICS, INC.
| RARECYTE, INC.
| SHOUTI INC.
| BASECAMP BIO INC.
| ADELA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-01-24

